Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Hodgkin Disease × Radiotherapy × Clear all

Phase

Status

Completed 46 Terminated 10 Active not recruiting 6 Unknown 4 Withdrawn 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 6 Breast Neoplasms 6 Small Cell Lung Carcinoma 5 Rectal Neoplasms 5 Neoplasms 4 Glioblastoma 4 Esophageal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma 2 Stomach Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Cancer Patients 1 Radiotherapy-induced Oral Mucositis 1 Radiation Injuries 1 Pelvic Neoplasms 1 Oropharyngeal Neoplasms 1 NSCLC 1

Interventions

tislelizumab 2 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 Cyclophosphamide 2 sintilimab 1 sargramostim 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 letermovir 1 Vinorelbine 1 Stem Cell Transplantation 1 Specimen Handling 1 Rituximab 1 Radiotherapy 1 Ocoxin 1 Neuropsychological Tests 1 Magnetic Resonance Spectroscopy 1 High-Intensity Interval Training 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Brentuximab Vedotin 1 Bone Marrow Purging 1 Blood Component Removal 1 Bendamustine Hydrochloride 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05627115 2023-11-29

RATiFY

University College, London

Phase 2 Not yet recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡